Carmen Scheibenbogen

Professor Doctor Carmen Scheibenbogen is an Internal Medicine physician, ME/CFS doctor and the Professor for Immunology and Deputy Chair, Institute of Medical Immunology, at the University Hospital Charité in Berlin, Germany. Her research focuses on the role of Epstein-Barr virus (EBV), particularly the characterization of EBV specific B cell and T cell response and the enhanced antibody response against EBV peptides in myalgic encephalomyelitis (ME) versus healthy controls.

EUROMENE
Professor Scheibenbogen is the Leader of the Biomarkers Working Group of EUROMENE, a European Union, COST Action CA15111, not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Diagnostic test
Professor Scheibenbogen helped create the CellTrend Diagnostic Test which may help identify a subset of 20-30% of all patients with ME/CFS. These patients have elevated levels of three auto-antibodies, i.e., against the b2-adrenergic receptor, against the muscarinic cholinergic receptor 3 (M3) and against the muscarinic cholinergic receptor 4 (M4).

Awards

 * 2016 Ramsay Award Program grant recipient, sponsored by the Solve ME/CFS Initiative for Autoimmune Signature in myalgic encephalomyelitis/chronic fatigue syndrome. This grant was shared with Madlen Löbel, Charité Universitätsmedizin Berlin.
 * 2017 Ramsay Award Program grant was awarded to a team comprised of Dr. Carmen Scheibenbogen and Dr. Franziska Sotzny of Charité Universitätsmedizin Berlin, sponsored by the Solve ME/CFS Initiative for researching immunometabolism of T cells and monocytes in ME/CFS.

Notable studies

 * 2014, Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome (Full Text)
 * 2015, Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome (Full Text)
 * 2015, Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome (Full Text)
 * 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome (Full Text)
 * 2017, Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray (Full Text)
 * 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE (Full Text)
 * 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease (Full Text)
 * 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME (Full Text)
 * 2018, The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome (Full Text)
 * 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review (Full text)
 * 2018, Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Full text)

Clinic location

 * Charité University Medicine, Berlin, Germany

Talks and interviews

 * 2014, Speaker at the 9th Invest in ME International ME Conference DVD available

Online presence

 * PubMed
 * Institute for Medical Immunology

Learn more

 * Curriculum Vitae for EUROMENE